Aronica E, Boer K, Redeker S, Spliet W G M, van Rijen P C, Troost D, Gorter J A
Department of (Neuro) Pathology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Neuroscience. 2007 Mar 2;145(1):185-96. doi: 10.1016/j.neuroscience.2006.11.041. Epub 2007 Jan 3.
Malformations of cortical development are recognized causes of chronic medically intractable epilepsy. An increasing number of observations suggests an important role for cation-chloride co-transporters (CCTs) in controlling neuronal function. Deregulation of their expression may contribute to the mechanisms of hyperexcitability that lead to seizures. In the present study the expression and cell-specific distribution of Na+-K+-2Cl--cotransporter (NKCC1) and K+-Cl--cotransporter (KCC2) were studied immunocytochemically in different developmental lesions, including focal cortical dysplasia (FCD) type IIB (n=9), hemimegalencephaly (HMEG, n=6) and ganglioglioma (GG, n=9) from patients with medically intractable epilepsy and in age-matched controls. In normal control adult cortex, NKCC1 displayed low neuronal and glial expression levels. In contrast KCC2 showed strong and diffuse neuropil staining. Notable glial immunoreactivity (IR) was not found for KCC2. NKCC1 was highly expressed in the majority of FCD, HMEG and GG specimens. NKCC1 IR was observed in neurons of different size, including large dysplastic neurons, in balloon cells (in FCD and HMEG cases) and in glial cells with astrocytic morphology. The immunoreactivity pattern of KCC2 in FCD, HMEG and GG specimens was characterized by less neuropil staining and more intrasomatic IR compared with control. KCC2 IR was observed in neurons of different size, including large dysplastic neurons, but not in balloon cells or in glial cells with astrocytic morphology. Double-labeling experiments confirmed the differential cellular distribution of the two CCTs and their expression in GABA(A) receptor (alpha1 subunit)-positive dysplastic neurons. The cellular distribution of CCTs, with high expression of NKCC1 in dysplastic neurons and altered subcellular distribution of KCC2 resembles that of immature cortex and suggests a possible contribution of CCTs to the high epileptogenicity of malformations of cortical development.
皮质发育畸形是慢性药物难治性癫痫的公认病因。越来越多的观察结果表明,阳离子 - 氯离子共转运体(CCTs)在控制神经元功能中起重要作用。其表达失调可能导致导致癫痫发作的过度兴奋机制。在本研究中,采用免疫细胞化学方法研究了钠 - 钾 - 2氯共转运体(NKCC1)和钾 - 氯共转运体(KCC2)在不同发育性病变中的表达和细胞特异性分布,这些病变包括来自药物难治性癫痫患者的IIB型局灶性皮质发育不良(FCD,n = 9)、半侧巨脑症(HMEG,n = 6)和神经节胶质瘤(GG,n = 9),并与年龄匹配的对照组进行比较。在正常对照成人皮质中,NKCC1在神经元和胶质细胞中的表达水平较低。相比之下,KCC2显示出强烈且弥漫的神经毡染色。未发现KCC2有明显的胶质免疫反应性(IR)。NKCC1在大多数FCD、HMEG和GG标本中高表达。在不同大小的神经元中观察到NKCC1 IR,包括大型发育异常神经元、气球样细胞(在FCD和HMEG病例中)以及具有星形胶质细胞形态的胶质细胞。与对照组相比,FCD、HMEG和GG标本中KCC2的免疫反应模式的特征是神经毡染色较少,胞体IR较多。在不同大小的神经元中观察到KCC2 IR,包括大型发育异常神经元,但在气球样细胞或具有星形胶质细胞形态的胶质细胞中未观察到。双标实验证实了两种CCTs的细胞分布差异及其在GABA(A)受体(α1亚基)阳性发育异常神经元中的表达。CCTs的细胞分布,即NKCC1在发育异常神经元中的高表达以及KCC2亚细胞分布的改变,类似于未成熟皮质,提示CCTs可能对皮质发育畸形的高致痫性有贡献。